Rhinitis: all 1,101 studies
Page 11 of 12. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum PratenseCompletedNCT00501527Phase 2
- Cetirizine Placebo Controlled Study For Perennial Allergic RhinitisCompletedNCT00490204Phase 3
- Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic RhinitisStatus unknownNCT00488176Phase 4
- Differential Adrenoreceptor Mediated Tachyphylaxis and UpregulationCompletedNCT00487032Phase 4
- Effect of a Nasal Bolus Allergen Challenge on Inflammatory MarkersCompletedNCT00483353Phase 1
- The Anti-allergic Effects of Specific ProbioticsCompletedNCT00480129Phase 1
- Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of SeasonCompletedNCT00474890Not applicable
- Intranasal Steroids and the Nasal Ocular ResponseCompletedNCT00473915Phase 4
- Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol SupplementsCompletedNCT00466596Phase 1
- Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis SymptomsCompletedNCT00460538Phase 4
- MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)CompletedNCT00446186Phase 2
- Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic RhinitisCompletedNCT00443495Phase 1/2
- Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic RhinitisCompletedNCT00439712Phase 4
- Oral Bacteria and Allergic Disease in ChildrenCompletedNCT00438646
- Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00430157Phase 2
- Oral Allergy Syndrome (OAS): a Pilot Study to Evaluate a Clinical Questionnaire as a Diagnostic ToolCompletedNCT00427479
- Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass PollenCompletedNCT00426179Phase 1/2
- Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)CompletedNCT00423995Phase 3
- Twin SUBLIVAC® Grasses Clinical Efficacy StudyCompletedNCT00422149Phase 3
- A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge ChamberCompletedNCT00420082Phase 2
- A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic RhinitisCompletedNCT00407927Phase 2
- Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)Status unknownNCT00406094Phase 4
- Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory InfectionsCompletedNCT00405899
- Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental ChamberCompletedNCT00404586Phase 1
- Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic RhinitisCompletedNCT00400998Phase 2
- To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)CompletedNCT00398151Phase 3
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1CompletedNCT00396149Phase 1
- Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic AdultsTerminatedNCT00387738Phase 2
- Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 2
- Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or PlaceboWithdrawnNCT00385463Not applicable
- A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)CompletedNCT00384475Phase 3
- Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)CompletedNCT00380705Phase 4
- Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00377728Phase 2
- A Trial of Point of Care Information in Ambulatory PediatricsCompletedNCT00368823Phase 3
- Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 YearsCompletedNCT00365469Phase 2
- Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
- Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine MetabolismCompletedNCT00362999
- Study Of Perennial Allergic RhinitisCompletedNCT00358475Phase 3
- Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic RhinitisCompletedNCT00355771Phase 4
- Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care SettingCompletedNCT00355160
- Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)CompletedNCT00348361Phase 1
- DNA Vaccine for Ragweed Allergic AdultsCompletedNCT00346086Phase 2
- Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in AdultsTerminatedNCT00344942Phase 3
- Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic RhinitisCompletedNCT00334698Not applicable
- Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic RhinitisCompletedNCT00325338Phase 2
- Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal PeriodCompletedNCT00325273Phase 3
- Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)CompletedNCT00319995Phase 3
- Treatment of Ragweed-Allergic Asthma With an Immunostimulatory DrugTerminatedNCT00318747Phase 2
- Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological ResponsesCompletedNCT00318695Phase 2
- Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00315523Phase 3
- Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen OxideStatus unknownNCT00312312Not applicable
- Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)CompletedNCT00305487Phase 3
- Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008Status unknownNCT00298337Phase 2/3
- A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal SecretionsCompletedNCT00297843
- Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
- Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent AsthmaTerminatedNCT00295737Not applicable
- The Effects of OC000459 on Nasal MediatorsCompletedNCT00290381Phase 1/2
- Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy AsthmaStatus unknownNCT00286416Not applicable
- Treatment of Rhinitis With Intranasal Vitamin ETerminatedNCT00281307Not applicable
- Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)CompletedNCT00261287Phase 3
- Perennial Allergic Rhinitis In Pediatric SubjectsCompletedNCT00257595Phase 3
- Study Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00253058Phase 3
- A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) AllergyCompletedNCT00250263Phase 4
- Safety and Efficacy Study of rEV131 in Allergic RhinitisStatus unknownNCT00247520Phase 1/2
- Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic RhinoconjunctivitisCompletedNCT00232518Not applicable
- Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic RhinitisCompletedNCT00227058Not applicable
- Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
- Long Term Safety Of GW685698X Via Nasal BiopsyCompletedNCT00224523Phase 3
- Seasonal Allergic Rhinitis and Driving AbilityTerminatedNCT00223587Phase 4
- The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure UnitCompletedNCT00209365Not applicable
- Primary Prevention of Atopic Disease by Perinatal Administration of ProbioticsCompletedNCT00200954Not applicable
- Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.CompletedNCT00200928Not applicable
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
- Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic RhinitisCompletedNCT00189449
- Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)CompletedNCT00163514Phase 3
- Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)CompletedNCT00163501Phase 3
- Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)CompletedNCT00163488Phase 3
- LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)CompletedNCT00160589Phase 4
- POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNCT00160537Phase 4
- Impact in Off-spring of Mothers After Perinatal Daily Intake of a ProbioticCompletedNCT00159523Not applicable
- A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)CompletedNCT00157937Phase 4
- EWO1 in Persistent Allergic Rhinitis PatientsStatus unknownNCT00153595Phase 2/3
- Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic RhinitisCompletedNCT00152412Phase 2
- Kansas City Community Environmental Remediation And Training (KC CERT)TerminatedNCT00144443Not applicable
- Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and AsthmaCompletedNCT00135642Phase 3
- Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen HayfeverCompletedNCT00135629Phase 3
- An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic RhinitisCompletedNCT00132925Phase 3
- Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
- Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNCT00117832Not applicable
- A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00116883Phase 3
- A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and AdultsCompletedNCT00116818Phase 3
- Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
- 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic RhinitisCompletedNCT00115089Phase 2
- Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3
- Perennial Allergic Rhinitis Study In Pediatric SubjectsCompletedNCT00108914Phase 3
- Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3
- A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).CompletedNCT00103454Phase 3
- An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)CompletedNCT00092885Phase 3
- Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal AllergiesCompletedNCT00078195Phase 2
- Nasal Irritation Study: Individual Factors in Nasal Irritant SensitivityCompletedNCT00041821Not applicable